Literature DB >> 24722503

Reply to 'Patient experience of the transition from Xalatan to generic latanoprost'.

L C Titcomb1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24722503      PMCID： PMC4094812          DOI： 10.1038/eye.2014.72

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  2 in total

1.  [Substitution of generic for brand medicines in primary care. Factors associated to refuse the change].

Authors:  J K Sagardui-Villamor; M Lacalle Rodríguez-Labajo; S Casado-Buendía
Journal:  Aten Primaria       Date:  2005-11-30       Impact factor: 1.137

2.  Patient experience of the transition from Xalatan to generic latanoprost.

Authors:  S L Painter; A L Mead
Journal:  Eye (Lond)       Date:  2014-04-11       Impact factor: 3.775
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.